C6 Modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorption
摘要:
1 (L-374,087) is a potent, selective, efficacious, and orally bioavailable thrombin inhibitor that contains a core 3-amino-2-pyridinone moiety. Replacement of the C6 pyridinone methyl group of 1 by a propyl group gave 5 (L-375,052), which retained all the excellent properties of 1, and also yielded higher plasma levels after oral dosing in dogs and rats. (C) 1998 Elsevier Science Ltd. All rights reserved.
C6 Modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorption
摘要:
1 (L-374,087) is a potent, selective, efficacious, and orally bioavailable thrombin inhibitor that contains a core 3-amino-2-pyridinone moiety. Replacement of the C6 pyridinone methyl group of 1 by a propyl group gave 5 (L-375,052), which retained all the excellent properties of 1, and also yielded higher plasma levels after oral dosing in dogs and rats. (C) 1998 Elsevier Science Ltd. All rights reserved.
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions and have the following structure: ##STR1## for example: ##STR2##
[EN] PYRIDINONE-THROMBIN INHIBITORS<br/>[FR] INHIBITEURS DE LA THROMBINE A BASE DE PYRIDINONE
申请人:MERCK & CO., INC.
公开号:WO1997001338A1
公开(公告)日:1997-01-16
(EN) Coupounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions and have structure (I), for example (a).(FR) L'invention porte sur des composés de formule (I) et notamment de formule (a) inhibiteurs de la thrombine et des occlusions thrombotiques associées.